Magnus Larsson

Title: Innovations of Magnus Larsson

Introduction

Magnus Larsson is a notable inventor based in Södertälje, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of enantiomerically enriched compounds. With a total of 2 patents, his work has implications for treating conditions related to insulin resistance syndrome.

Latest Patents

Larsson's latest patents include a process for the preparation of enantiomerically enriched compounds. This invention focuses on novel resolution methods that are useful in creating intermediates beneficial for pharmacological effects on insulin resistance syndrome. Specifically, it defines a process for preparing the (S)-enantiomer of certain 2-ethoxy-3-(4-hydroxyphenyl)propanoic acids and their derivatives. Another significant patent is for the process of preparing omeprazole, a medication used to treat certain stomach and esophagus problems.

Career Highlights

Magnus Larsson is associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to contribute to innovative solutions in the pharmaceutical industry. His expertise in the preparation of complex compounds has positioned him as a valuable asset in the field.

Collaborations

Larsson has collaborated with several professionals, including Maria Larsson and Sivaprasad Sivadasan. These collaborations have enhanced the development of his innovative processes and have contributed to the success of his patents.

Conclusion

Magnus Larsson's contributions to pharmaceutical innovations demonstrate his commitment to advancing medical science. His patents reflect a deep understanding of complex chemical processes that can lead to significant health benefits.